Article
Long-Term Outcome of Sequential Therapy with Lamivudine Followed by Interferon-β in Nucleoside-Naive, Hepatitis B e-Antigen-Positive Patients with Chronic Hepatitis B Virus Genotype C Infection.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research - 1 Aug 2015
Enomoto Masaru, Nishiguchi Shuhei, Tamori Akihiro, Kozuka Ritsuzo, Hayashi Takehiro, Kohmoto Madoka Toyama, Jomura Hisato, Morikawa Hiroyasu, Murakami Yoshiki, Shiomi Susumu, Kawada Norifumi
Abstract excerpt
It is unclear whether the combination of a nucleos(t)ide analog and interferon (IFN) is superior to monotherapy for treating chronic hepatitis B. In this study, we report the long-term outcomes of sequential therapy using lamivudine followed by IFN-β. This study included 24 hepatitis B e-antigen (HBeAg)-positive patients with chronic hepatitis B virus (HBV) genotype C infection who were treated with lamivudine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
